Benjamin L. Shneider, MD
- Gastroenterology

Service Chief, Pediatric Gastroenterology, Hepatology and Nutrition
Professor of Pediatrics, Baylor College of Medicine
George Peterkin Endowed Chair
Phone:
832-822-3131
Languages: English
Office location:
Texas Medical Center
6701 Fannin Street
Suite 1100
Houston, TX 77030
Get to know Benjamin L. Shneider, MD
Dr. Shneider's leadership goal is to leverage the wide-ranging clinical and research expertise of an exceptionally talented section to provide compassionate, state-of-the-art, discipline-leading and evidence-based care for children with all types of gastrointestinal, hepatic, pancreatic and nutritional disorders. Rapidly-paced advances in biomedical knowledge provide an unprecedented opportunity to simultaneously advance both clinical care and the science of medicine. As Chief of Pediatric Gastroenterology, Hepatology and Nutrition at Texas Children's Hospital and the Baylor College of Medicine, Dr. Shneider will encourage and lead expanding activities in both education and research in order to optimally capitalize on these rapidly paced biomedical advances with the ultimate goal of providing outstanding evidence-based care for the patients and their families who entrust their care to the section.
Dr. Shneider’s research career began during his undergraduate studies at Stanford University. His interest in Pediatric Hepatology was sparked by experiences during medical school at The University of Chicago. He completed a residency in Pediatrics at The Children's Hospital, Boston with subsequent fellowship training in Pediatric Gastroenterology/Hepatology at the Yale University School of Medicine. He served as the Director of Pediatric Hepatology at the Mount Sinai School of Medicine for nine years and at Children’s Hospital of Pittsburgh of UMPC for seven years, until his recruitment to Texas Children's Hospital and the Baylor College of Medicine in 2015 as Section Chief and Head of Pediatric Gastroenterology, Hepatology and Nutrition.
Dr. Shneider is a physician-scientist with varied areas of expertise including a clinical focus in cholestatic liver diseases and portal hypertension, basic and translational investigations of bile acid homeostasis, and basic research on mechanisms of intestinal carcinogenesis. Dr. Shneider’s primary research focus is on clinical investigations of pediatric liver diseases. Recent work has been conducted in the context of the Childhood Liver Disease Research Network (ChiLDReN), an NIDDK-funded multi-center effort. Dr. Shneider has led a number of studies conducted within ChiLDReN advancing understanding of the natural history of biliary atresia. He has led a major multi-centered randomized placebo-controlled trial of a novel intestinal bile acid transport inhibitor in the treatment of pruritus in the Alagille syndrome, a disease manifest by profound cholestasis. Dr. Shneider has led a large-scale multi-center study of the utility of the transient elastographic measurement of liver stiffness in pediatric cholestatic liver disease. Dr. Shneider’s expertise as a physician-scientist has been leveraged in his current mentorship of three faculty in the section addressing novel approaches to newborn screening for biliary atresia, analysis of the fecal microbiome in the clinical course of infants with biliary atresia and assessment of novel markers of immunodeficiency in children with chronic liver disease. Dr. Shneider has consistently pursued advances in evidence-based approaches to the diagnosis and treatment of pediatric liver disorders with particular interest in issues related to chronic cholestasis, cirrhosis and portal hypertension.
Introducing the International Multi-center Pediatric Portal Hypertension Registry
IMPPHR - International Multicenter Pediatric Portal Hypertension Registry
Education
School | Education | Degree | Year |
---|---|---|---|
Yale University - New Haven Hospital | Fellowship | Pediatric Gastroenterology | 1992 |
Children's Hospital Boston | Residency | Pediatrics | 1989 |
Children's Hospital Boston | Internship | Pediatrics | 1987 |
University of Chicago Medical Center | Medical School | Medical Degree | 1986 |
Organizations
Organization Name | Role |
---|---|
American Society for Clinical Investigators | Member |
American Association for the Study of Liver Disease | Fellow |
Society for Pediatric Research | Member |
American Gastroenterological Association | Member |
North American Society for Pediatric Gastroenterology, Hepatology and Nutrition | Member |
American Pediatric Society | Member |
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Black D, Mack C, Kerkar N, Miloh T, Sundaram S, Anand R, Gupta A, Alonso E, Arnon R, Bulut P, Karpen S, Lin C-H, Rosenthal P, Ryan M, Squires R, Valentino P, Elsea S. Shneider BL. A prospective trial of withdrawal and reinstitution of ursodeoxycholic acid in pediatric primary sclerosing cholangitis. Hepatol. Commun. 3:1482-1495, 2019
Harpavat S, Garcia-Prats J, Anaya C, Brandt M, Lupo P, Finegold M, Obuobi A, ElHennawy A, Jarriel W, Shneider B. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements. JAMA 323:1141-1150, 2020.
Shneider BL, Goodrich NP, Ye W, Sawyers C, Molleston JP, Merion RM, Leung DH, Karpen SJ, Kamath BM, Cavallo L, Kasper KS, Teckman JH, Squires JE, Sundaram SS, Rosenthal P, Romero R, Murray KF, Loomes KM, Jensen MK, Bezerra JA, Bass LM, Sokol RJ, Magee JC, for the Childhood Liver Disease Research Network (ChiLDReN). Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease. Hepatol. Commun. 4:1694-1707, 2020
Shneider BL, Cortes-Santiago N, Schady DA, Krishnamoorthy S, Thevananther S, Rajapakshe K, Perera D, Huang S, Coarfa C. Constitutive Activation of Mitogen-activated Protein Kinase Kinase (MEK1) in Ileal Enterocytes Leads to Dysplasia and a Predisposition to Cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 320:G366-G379, 2021
Shneider BL, Spino CA, Kamath BM, Magee JC, Ignacio RV, Huang S, Horslen SP, Molleston JP, Miethke AG, Kohli R, Leung DH, Jensen MK, Loomes KM, Karpen SJ, Mack C, Rosenthal P, Squires RH, Baker A, Rajwal S, Kelly D, Sokol RJ, Thompson RJ, for ChiLDReN and UK IMAGO/IMAGINE Investigators. Impact of Long-term Administration of Maralixibat on Children with Cholestasis Secondary to Alagille Syndrome. Hepatol Commun. 6:1922-1933,2022
Bass LM, Ye W, Hawthorne K, Leung DH, Murray KF, Molleston JP, Romero R, Karpen S, Rosenthal P, Loomes KM, Wang KS, Squires RH, Miethke A, Ng VL, Horslen S, Jensen MK, Sokol RJ, Magee J, Shneider BL, on behalf of ChiLDReN. The Risk of Variceal Hemorrhage and Pre-Transplant Mortality in Children with Biliary Atresia. Hepatology. 76:712-726, 2022